Clinical Significance of Serum Biomarker S100B to Predict Outcome After Traumatic Brain Injury

@article{Gahlot2017ClinicalSO,
  title={Clinical Significance of Serum Biomarker S100B to Predict Outcome After Traumatic Brain Injury},
  author={G. Gahlot and Y. Soni and G. Joshi and R. Saxena},
  journal={Indian Journal of Mednodent and Allied Sciences},
  year={2017},
  volume={5},
  pages={24-29}
}
  • G. Gahlot, Y. Soni, +1 author R. Saxena
  • Published 2017
  • Medicine
  • Indian Journal of Mednodent and Allied Sciences
  • Background: Traumatic brain injury (TBI) is a common cause of death and disability, worldwide. Early recognition of patients with brain cellular damage allows for early rehabilitation and patient outcome improvement. Serum protein S-100B determinations have been widely suggested the most promising biomarker for TBI. It has been proposed that this marker is useful in a Neurointensive Care Unit (NICU) as a monitoring parameter. The main objective of this study is to assess the value of including… CONTINUE READING
    3 Citations